Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of SEPT2 mRNA | decreases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SEPT2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SEPT2 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SEPT2 mRNA | decreases expression | 20018196
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of SEPT2 mRNA | decreases expression | 15336504
|
D004610 |
Ellagic Acid |
Ellagic Acid results in increased expression of SEPT2 mRNA | increases expression | 12002526
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SEPT2 mRNA | affects cotreatment|increases expression | 17183730
|
C027185 |
indirubin |
indirubin results in decreased expression of SEPT2 mRNA | decreases expression | 15056799
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of SEPT2 mRNA | decreases expression | 16807920
|
D015741 |
Metribolone |
Metribolone results in increased expression of SEPT2 protein | increases expression | 17152098
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of SEPT2 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.68 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.07 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.75 | 18287403 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.83 | 3712494 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.45 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.06 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.68 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.86 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.86 | 18558336 18940202 17688650 18177632 17507914 20603192 18985861 16609825 18316065 19232924 17157402 19460635 18775368 15238991 18396377 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.24 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.14 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.49 | 8888407 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
2.87 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.87 | 3084413 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.73 | 7296757 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.66 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
6.96 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.96 | 20889678 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.75 | 20734317 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.25 | 19486331 9022650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.97 | 8156756 14531868 12868966 2524372 11298694 8970840 11906362 18759878 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.64 | 3621924 2952479 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.42 | 16192314 7440962 9653073 18692083 8291058 9328219 6482804 6679447 9022650 18289764 1440618 11289319 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.42 | 19416960 15619225 12594235 11834606 19739265 16109766 11287661 17522070 16393943 15968718 17906064 12392966 18713872 11421492 11739529 16227642 10663392 16081117 11743745 14725611 11461765 16177239 12153990 19085960 19420014 14986274 12540782 12958197 19923254 12705907 18071297 10774834 11529661 16781746 19370779 2444490 17562736 10915739 19164858 16485898 14550746 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.42 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.32 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.20 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.33 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.13 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.00 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.71 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.47 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.26 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.49 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.49 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.44 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.10 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.29 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.24 | 6705139 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.89 | 16983495 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.19 | 7505956 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.67 | 6705139 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.06 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.81 | 16870215 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.11 | 15034207 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
6.15 | 11275354 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.80 | 16612254 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.24 | 9022650 8074119 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.27 | 12587719 15629191 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.08 | 6582329 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 17596541 16294345 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.28 | 15034207 9327722 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 19460945 19014921 12969438 11587558 19784758 12587719 16611625 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.37 | 17185352 16871587 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
2.61 | 6587162 1399818 598648 3712494 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.48 | 17228818 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.74 | 19513568 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.29 | 18765137 18803445 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.17 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.23 | 17596541 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.52 | 3581430 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.55 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.55 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.99 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.55 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.24 | 3988306 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.50 | 16870215 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.66 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.69 | 6228378 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.02 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.76 | 12752131 11422049 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.48 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.32 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.83 | 17978042 1511512 16876388 3137016 11738929 14763951 15475178 11044598 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.75 | 8532709 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.89 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.76 | 12833885 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.99 | 6582329 3712494 1399818 7505956 6587162 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.45 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.71 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.32 | 8074119 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.82 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.12 | 10982225 |